MOTS-c and insulin sensitivity in mouse metabolic experiments
Animal research · 2015
- What was studied
- Mouse metabolic experiments and cell assays. Glucose tolerance n=7 and insulin clamp n=6–8 as reported in Figure 5.
- Main finding
- MOTS-c improved glucose tolerance and insulin-stimulated glucose disposal in mice. Hepatic glucose production during the clamp did not show a significant treatment difference.
Reported findings and study design
Vehicle-controlled metabolic testing in mice, including glucose tolerance (n=7) and insulin clamp (n=6–8).
Population or model Mouse metabolic experiments and cell assays. Glucose tolerance n=7 and insulin clamp n=6–8 as reported in Figure 5.
Dose, route and schedule
5 mg/kg/day intraperitoneally for seven days in glucose tolerance and insulin-clamp experiments. Separate diet-induced obesity experiments used 0.5 mg/kg/day intraperitoneally.
Protocol source ↗ · Original Figure 5–6 captions.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Glucose tolerance and insulin-stimulated disposal | Improved in mice receiving MOTS-c. | After 7 days of 5 mg/kg/day intraperitoneally |
| Hepatic glucose production during insulin clamp | No significant between-group difference reported. | |
| High-fat diet body weight and insulin resistance | Both reduced with MOTS-c in the prevention experiment. |
Source for these results ↗ · Reviewed 2026-11-14
Study limitations and source details
Study limitations
- These are separate mouse and cell experiments. There was no human dosing arm.
Source details
Original abstract and published Figure 5–6 captions; effect sizes were not digitized.
Sources checked
Citation
C. Lee, J. Zeng, B. G. Drew, et al.. MOTS-c and insulin sensitivity in mouse metabolic experiments Cell Metab. 2015;21(3):443–454.
Study source ↗ · DOI 10.1016/j.cmet.2015.02.009 · Bibliography entry · Link to this summary